Dr. Sergey Brezgin is affiliated with the National Medical Research Center for Tuberculosis and Infectious Diseases in Moscow, Russia, as well as the Institute of Immunology, Federal Medical Biological Agency in Moscow, Russia. His research interests mainly focus on cccDNA; innate immunity; viral replication; dna damage; CRISPR/Cas9; gene editing; extracellular vesicles; targeted drug delivery; biological delivery; interferon-stimulated genes; and epigenetics. His scientific output includes 34 publications in various journals with an h-index of 10 (Scopus, March 2024).